Podcast
Questions and Answers
How does the parasympathetic nervous system influence gastrointestinal (GI) motility, and which specific receptor type is primarily involved in this process?
How does the parasympathetic nervous system influence gastrointestinal (GI) motility, and which specific receptor type is primarily involved in this process?
The parasympathetic nervous system increases GI motility through muscarinic cholinergic receptors.
What is the functional outcome of administering a cholinomimetic drug, and how does it relate to the action of acetylcholine (ACh)?
What is the functional outcome of administering a cholinomimetic drug, and how does it relate to the action of acetylcholine (ACh)?
A cholinomimetic drug mimics the action of acetylcholine, enhancing cholinergic neurotransmission.
How do cholinesterase inhibitors affect acetylcholine levels in the synapse, and what are the potential consequences of this action?
How do cholinesterase inhibitors affect acetylcholine levels in the synapse, and what are the potential consequences of this action?
Cholinesterase inhibitors increase acetylcholine levels by preventing its breakdown, leading to enhanced cholinergic effects which, if excessive, can cause a cholinergic crisis.
What distinguishes reversible cholinesterase inhibitors from irreversible ones in terms of their mechanism of action and clinical implications?
What distinguishes reversible cholinesterase inhibitors from irreversible ones in terms of their mechanism of action and clinical implications?
Describe the dual mechanism through which Atropine influences heart rate at different doses.
Describe the dual mechanism through which Atropine influences heart rate at different doses.
How does Atropine affect exocrine gland secretions, and what is the underlying mechanism for these effects?
How does Atropine affect exocrine gland secretions, and what is the underlying mechanism for these effects?
What is the primary mechanism by which scopolamine induces sedation, and how does its action differ from that of Atropine?
What is the primary mechanism by which scopolamine induces sedation, and how does its action differ from that of Atropine?
Explain how Tiotropium achieves bronchodilation in the treatment of asthma or COPD, and specify which muscarinic receptor subtypes are involved.
Explain how Tiotropium achieves bronchodilation in the treatment of asthma or COPD, and specify which muscarinic receptor subtypes are involved.
How does nicotine affect autonomic ganglia at low and high doses, and what accounts for the differing effects?
How does nicotine affect autonomic ganglia at low and high doses, and what accounts for the differing effects?
Describe the physiological effects of nicotine on the cardiovascular system, and explain how these effects are mediated.
Describe the physiological effects of nicotine on the cardiovascular system, and explain how these effects are mediated.
What are ganglionic blockers, and how do they influence the balance between parasympathetic and sympathetic tone?
What are ganglionic blockers, and how do they influence the balance between parasympathetic and sympathetic tone?
What are the expected effects of a ganglionic blocker on ocular function, and how do they relate to the drug's mechanism of action?
What are the expected effects of a ganglionic blocker on ocular function, and how do they relate to the drug's mechanism of action?
How does hemicholinium affect acetylcholine synthesis, and what specific step in the process does it inhibit?
How does hemicholinium affect acetylcholine synthesis, and what specific step in the process does it inhibit?
What enzymatic activity is inhibited by physostigmine, and how does it differ from the mechanism of action of neostigmine?
What enzymatic activity is inhibited by physostigmine, and how does it differ from the mechanism of action of neostigmine?
How does the action of pralidoxime (2-PAM) counteract the effects of organophosphate poisoning, and what limitations exist in its effectiveness?
How does the action of pralidoxime (2-PAM) counteract the effects of organophosphate poisoning, and what limitations exist in its effectiveness?
How do irreversible cholinesterase inhibitors such as nerve gases lead to cholinergic crisis, and what are the key signs of such a crisis?
How do irreversible cholinesterase inhibitors such as nerve gases lead to cholinergic crisis, and what are the key signs of such a crisis?
What is the role of cholinesterase in the cholinergic synapse, and how does its function contribute to normal neurotransmission?
What is the role of cholinesterase in the cholinergic synapse, and how does its function contribute to normal neurotransmission?
How does the selectivity of muscarinic receptor antagonists influence their therapeutic applications and side effect profiles?
How does the selectivity of muscarinic receptor antagonists influence their therapeutic applications and side effect profiles?
What are the primary mechanisms by which anticholinergic drugs affect urinary function, and for what conditions might they be used?
What are the primary mechanisms by which anticholinergic drugs affect urinary function, and for what conditions might they be used?
How does the use of Atropine influence accommodation, and in what medical circumstances is this effect useful?
How does the use of Atropine influence accommodation, and in what medical circumstances is this effect useful?
Explain how the differing selectivity of pilocarpine and bethanechol impacts their uses.
Explain how the differing selectivity of pilocarpine and bethanechol impacts their uses.
Explain the concept of 'aging' as it relates to the irreversible inhibition of acetylcholinesterase by organophosphates. How does aging affect treatment strategies for organophosphate poisoning?
Explain the concept of 'aging' as it relates to the irreversible inhibition of acetylcholinesterase by organophosphates. How does aging affect treatment strategies for organophosphate poisoning?
How do the mechanisms of action of scopolamine and dimenhydrinate (Dramamine) differ in preventing motion sickness, and what are the clinical implications of these differences?
How do the mechanisms of action of scopolamine and dimenhydrinate (Dramamine) differ in preventing motion sickness, and what are the clinical implications of these differences?
In the context of anesthesia, what is the rationale for using anticholinergic drugs like glycopyrrolate before surgery, and how does glycopyrrolate's properties make it suitable for this purpose?
In the context of anesthesia, what is the rationale for using anticholinergic drugs like glycopyrrolate before surgery, and how does glycopyrrolate's properties make it suitable for this purpose?
Describe the role of M2 muscarinic receptors as autoreceptors in the context of cholinergic neurotransmission in the lungs, and explain how blocking these receptors with a drug like ipratropium affects acetylcholine release and airway function.
Describe the role of M2 muscarinic receptors as autoreceptors in the context of cholinergic neurotransmission in the lungs, and explain how blocking these receptors with a drug like ipratropium affects acetylcholine release and airway function.
How does chronic exposure to nicotine lead to desensitization of nicotinic receptors at autonomic ganglia, and what are the clinical consequences of this desensitization in terms of cardiovascular function and blood pressure regulation?
How does chronic exposure to nicotine lead to desensitization of nicotinic receptors at autonomic ganglia, and what are the clinical consequences of this desensitization in terms of cardiovascular function and blood pressure regulation?
Explain the rationale behind using trimethaphan camsylate in the management of hypertensive crisis, and describe the mechanism of action by which this drug achieves rapid reduction in blood pressure.
Explain the rationale behind using trimethaphan camsylate in the management of hypertensive crisis, and describe the mechanism of action by which this drug achieves rapid reduction in blood pressure.
What are the key considerations when treating a patient presenting with the classic 'SLUDGE' symptoms (Salivation, Lacrimation, Urination, Defecation, Gastrointestinal distress, Emesis) indicative of cholinergic toxicity, and how do these considerations guide the choice of antidote and supportive care?
What are the key considerations when treating a patient presenting with the classic 'SLUDGE' symptoms (Salivation, Lacrimation, Urination, Defecation, Gastrointestinal distress, Emesis) indicative of cholinergic toxicity, and how do these considerations guide the choice of antidote and supportive care?
Compare and contrast the therapeutic uses of neostigmine and edrophonium in the context of myasthenia gravis, including the mechanisms of action. Why is edrophonium used diagnostically and neostigmine chronically?
Compare and contrast the therapeutic uses of neostigmine and edrophonium in the context of myasthenia gravis, including the mechanisms of action. Why is edrophonium used diagnostically and neostigmine chronically?
How does the pathophysiology of glaucoma relate to cholinergic mechanisms, and what is the rationale for using pilocarpine to manage this condition?
How does the pathophysiology of glaucoma relate to cholinergic mechanisms, and what is the rationale for using pilocarpine to manage this condition?
A patient with Alzheimer’s disease is prescribed donepezil. What is the cholenergic mechanism of this drug, and what is its purpose for Alzheimer's?
A patient with Alzheimer’s disease is prescribed donepezil. What is the cholenergic mechanism of this drug, and what is its purpose for Alzheimer's?
How does the mechanism of action of Vesamicol differ from that of Hemicholinium in modulating cholinergic neurotransmission?
How does the mechanism of action of Vesamicol differ from that of Hemicholinium in modulating cholinergic neurotransmission?
When are direct cholinergic receptor agonists indicated, and how do they differ from cholinesterase inhibitors in their mechanism of action?
When are direct cholinergic receptor agonists indicated, and how do they differ from cholinesterase inhibitors in their mechanism of action?
How does the chemical structure of atropine contribute to its pharmacological effects, particularly in terms of its ability to interact with muscarinic receptors and its distribution in the body?
How does the chemical structure of atropine contribute to its pharmacological effects, particularly in terms of its ability to interact with muscarinic receptors and its distribution in the body?
In toxicology, how does the concept of 'muscarinic excess' apply to organophosphate poisoning, and which specific signs and symptoms reflect this excess?
In toxicology, how does the concept of 'muscarinic excess' apply to organophosphate poisoning, and which specific signs and symptoms reflect this excess?
In what clinical scenarios would a drug that selectively blocks nicotinic receptors at autonomic ganglia be useful? How would it impact the sympathetic and parasympathetic nervous systems?
In what clinical scenarios would a drug that selectively blocks nicotinic receptors at autonomic ganglia be useful? How would it impact the sympathetic and parasympathetic nervous systems?
How are cholinesterase deficiencies diagnosed and managed, and what role do genetic factors play in the variable expression of cholinesterase activity?
How are cholinesterase deficiencies diagnosed and managed, and what role do genetic factors play in the variable expression of cholinesterase activity?
Describe how muscarinic receptors in the sinoatrial (SA) node of the heart mediate the effects of the parasympathetic nervous system on heart rate. Explain the mechanism.
Describe how muscarinic receptors in the sinoatrial (SA) node of the heart mediate the effects of the parasympathetic nervous system on heart rate. Explain the mechanism.
A patient that overdoses on methacholine shows signs of bronchoconstriction. Why is epinephrine the antidote of choice for the clinician? Explain.
A patient that overdoses on methacholine shows signs of bronchoconstriction. Why is epinephrine the antidote of choice for the clinician? Explain.
A patient with Alzheimer's is taking a cholinesterase inhibitor but their memory is beginning to decline. How might combining muscarinic agonists or antagonists provide a synergistic effect?
A patient with Alzheimer's is taking a cholinesterase inhibitor but their memory is beginning to decline. How might combining muscarinic agonists or antagonists provide a synergistic effect?
Flashcards
Parasympathetic Nervous System
Parasympathetic Nervous System
Parasympathetic nervous system uses long preganglionic neurons and short postganglionic neurons to communicate with target organs using acetylcholine (ACh).
Cholinomimetics
Cholinomimetics
Drugs that mimic the effects of acetylcholine by binding to cholinergic receptors directly.
Cholinergic Agonists
Cholinergic Agonists
Natural and synthetic agents that directly bind to and activate cholinergic receptors.
Cholinesterase Inhibitors
Cholinesterase Inhibitors
Signup and view all the flashcards
Reversible vs Irreversible Cholinesterase Inhibitors
Reversible vs Irreversible Cholinesterase Inhibitors
Signup and view all the flashcards
Muscarinic Antagonists
Muscarinic Antagonists
Signup and view all the flashcards
Ganglionic Blockers
Ganglionic Blockers
Signup and view all the flashcards
Hemicholine
Hemicholine
Signup and view all the flashcards
Vesamicol
Vesamicol
Signup and view all the flashcards
Acetyltransferase
Acetyltransferase
Signup and view all the flashcards
Acetylcholinesterase (AChE)
Acetylcholinesterase (AChE)
Signup and view all the flashcards
mAChR (m1, m3, m5)
mAChR (m1, m3, m5)
Signup and view all the flashcards
mAChR (m2, m4)
mAChR (m2, m4)
Signup and view all the flashcards
mAChR Agonists
mAChR Agonists
Signup and view all the flashcards
mAChR Antagonists
mAChR Antagonists
Signup and view all the flashcards
M1 Receptors
M1 Receptors
Signup and view all the flashcards
M2 Receptors
M2 Receptors
Signup and view all the flashcards
M3 Receptors
M3 Receptors
Signup and view all the flashcards
M2 Ach R
M2 Ach R
Signup and view all the flashcards
Cholinomimetics: Structural Analogs of ACh
Cholinomimetics: Structural Analogs of ACh
Signup and view all the flashcards
Natural Cholinergic Agonists
Natural Cholinergic Agonists
Signup and view all the flashcards
Synthetic Cholinergic Agonists
Synthetic Cholinergic Agonists
Signup and view all the flashcards
Pilocarpine Use
Pilocarpine Use
Signup and view all the flashcards
Bethanechol Use
Bethanechol Use
Signup and view all the flashcards
Cholinomimetics: Cholinesterase Inhibitors
Cholinomimetics: Cholinesterase Inhibitors
Signup and view all the flashcards
Reversible Cholinesterase Inhibitors
Reversible Cholinesterase Inhibitors
Signup and view all the flashcards
Irreversible Cholinesterase Inhibitors: Insecticides
Irreversible Cholinesterase Inhibitors: Insecticides
Signup and view all the flashcards
Nonselective Cholinesterase Inhibitors
Nonselective Cholinesterase Inhibitors
Signup and view all the flashcards
Cholinesterase Inhibitors Mechanism
Cholinesterase Inhibitors Mechanism
Signup and view all the flashcards
Cholinergic Crisis
Cholinergic Crisis
Signup and view all the flashcards
Physostigmine (Eserine)
Physostigmine (Eserine)
Signup and view all the flashcards
Neostigmine
Neostigmine
Signup and view all the flashcards
Edrophonium
Edrophonium
Signup and view all the flashcards
Donepezil (Aricept)
Donepezil (Aricept)
Signup and view all the flashcards
Echolthipate (phospholine iodide)
Echolthipate (phospholine iodide)
Signup and view all the flashcards
Anti-muscarinics
Anti-muscarinics
Signup and view all the flashcards
Atropine
Atropine
Signup and view all the flashcards
Scopolamine
Scopolamine
Signup and view all the flashcards
Darifenacin (Enablex)
Darifenacin (Enablex)
Signup and view all the flashcards
Tiotropium (Spiriva)
Tiotropium (Spiriva)
Signup and view all the flashcards
Study Notes
Cholinergic Parasympathetic Review Summary
- Clinical target sites include GI motility, secretion (bronchiole, GI, salivary), motion sickness, bradycardia, bladder, glaucoma, CNS: AD, dystonias, pain, and addiction
Cholinergics
- Agonists and Antagonists are the main focus
Lecture Objectives
- Drug manipulation of the cholinergic system will be examined
- The objective is to mimic the cholinergic system
- Cholinomimetics can be natural or synthetic Ag
- Cholinesterase and inhibitors can be reversible or irreversible
- Muscarinic R ANT include Atropine, Scopolamine, and synthetic compounds
- Nicotinic R Ag is also a topic
- Nicotinic R ANT- ganglionic blockers exist
- Mechanism/effects, therapeutic use, and adverse effects are the main focus
Cholinergic System
- Neurotransmitters are key component
- There is selectivity between nicotinic and muscarinic receptors
- The blood-brain barrier (BBB) is a factor
- IV doses target "postganglionic" areas
- Peripheral roles include NMJ and ANS
- nACh and mACh receptors are physiologically important
Acetylcholine
- Hemicholine and Vesamicol inhibits the recycling of catechol
- Acetylcholinesterase (AChE) is found at every synapse and at target tissue
Muscarinic Cholinergic Receptor
- mAChR (m1-5) increases Ca2+ and contraction
- Gq/11 leads to PLC, IP3 DAG and Ca++ increasing PKC
- Gi/o inhibits AC and cAMP
- Ach, muscarine & carbachol are agonists with higher affinity for musc recep
- Atropine & scopolamine are antagonists and more selective at musc recep
Parasympathetic/mACH R Innervation
- m1 affects ganglia and gastric, parietal, and salivary glands
- m2 impacts the heart, smooth muscle, and autonomic nerve terminals
- m3 affects smooth muscle and gastric and salivary glands
- m3 also affects bladder and vascular smooth muscle
- m4 is for auto- and hetero-receptors
- m5 causes low-level expression and affects cerebral artery smooth muscle
Effects of ANS on Pacemaker Potentials in SA Node
- Physiologically, M2 Ach R are slowing via
- Increasing K+ channels to hyperpolarization
- Decreasing Vg Ca++ channel activity, ramp
- Decreasing threshold to reach takes longer
- Decreasing SA firing and action potential
Case Study
- A 20-year-old woman presents to the ED with excessive thirst, lethargy, vomiting, acute abdominal pain, and constipation
- She had been camping, hanging out with friends, and foraging in the forest
- She exhibits tachycardia (HR165) and hypertension, is disoriented, has blurred vision, complains of a rainbow halo and leprechauns, is lethargic, and has "flushed" yet dry skin
- The question is what might be going on with this individual
Cholinomimetics: Structural Analogs of ACh
- These mimic Ach directly via binding
- Natural sources include Muscarine from Amanita muscaria (mAChR) and Pilocarpine from Pilocarpus jaborandi (m>n Ach R)
- Synthetic options are Carbachol (m>n AchR), Methacholine (mAChR), and Bethanechol
- Substitution changes selectivity and sensitivity to Achase
- They are used therapeutically
- Pilocarpine can be used for occular surgery/glaucoma
- Bethanechol is used post-surgery for urinary retention
Cholinomimetics: Indirectly via Inhibition of Degradation
- Cholinesterase inhibitors can be reversible (carbamate derivatives) or irreversible (organophosphates)
- They inhibit both acetylcholinesterase and plasma cholinesterase
- ACh activity increases only where ACh is actively released
- Cholinergic crisis has effects at muscarinic and nicotinic ACh receptors
Cholinesterase and its Inhibitors: Lethal AChase-I
- Lethal AChase-I causes restlessness, abdominal distress, spasms, defecation, urination, constricted pupils, muscle twitches, paralysis, salivation, sweating, difficulty breathing (bronchiole constriction, secretion), convulsions, and respiratory failure
- AChase - selectivly interacts depending on the N and esteric structures
Reversible Cholinesterase Inhibitors
- These are competitive inhibitors but chemically diverse
- Physostigmine (Eserine- Alkaloid of calabar bean) crosses the BBB and is used for glaucoma to decrease intraocular pressure
- Neostigmine does not cross the BBB and has direct nAChR activity
- Taken po to treat myasthenia gravis and stimulates GI contractions and gastric secretions
- Edrophonium is short acting and given IV to diagnose myasthenia gravis
Reversible Cholinesterase Inhibitors - Drugs for Alzheimer's
- Donepezil (Aricept) can maintain or improve cognitive function with AD (PD), crosses the BBB, is specific, has fewer side effects and no hepatic toxicity
- Rivastigmine (Exelon) and Galantamine (Reminyl) are alternatives
Irreversible Cholinesterase Inhibitors
- There are 100s of compounds that downgrade availability of the enzymes
- De novo synthesis is required for recovery
- Nerve gases (sarin, mustard gas, DFP) are sprays/aerosols that readily taken by the body
- Highly lipid soluble and rapidly penetrate reaching all synapses
- Reactivation with 2-PAM may only occur within minutes
- Insecticides are made as a toxic design for insects
- Lipid soluble and concentrated in adipose
- Atropine blocks muscarinic effects and accumulation causes mammalian toxicity
Mechanism of Irreversible Inhibitors
- Fast process involving Serine and Histidine, and competing nucleophile which the 2-PAM is
- They can no longer interact with ach
Reactivators
- Prior to "aging," pralidoxime (2-PAM) can reactivate the enzyme via phosphoryl group
- Some AChase activity with 2-PAM is not used with reversible AChase Inhibitors
Therapeutic Use: Irreversible ACHase Inhibitors
- Echolthipate (phospholine iodide) is used as an eye drop
- It is an organophosphate used clinically to treat glaucoma
- It is stable with a duration of action >100 hours
- Topical application can have systemic side effects
- Other side effects can be treated with Atropine or 2-PAM and can cause risk of cataract development after use
Muscarinic R Antagonists
- Anti-muscarinics block the effect ach at the musc receptor.
- ANT binding domain is distinct yet overlapping Ag site
- High affinity binding (IC 50? High or low)
Muscarinic Receptor Antagonists
- Atropine is a non-selective mACh R ANT with the source being a number of plants
- Atropa belladonna (deadly nightshade), Datura stramonium are examples
- Blocks contraction of smooth muscle cells and mucosal secretion
- Selective at therapeutic doses
- Pharmacological Effects : Exocrine glands secretions decrease includes gastric, bronchiole, salivary, sweat
- GI/Urinary Tract: ↓ excessive tone; no ∆ normal motility, ↓spasms of cardiac sphincter of stomach, Relaxes biliary tract,
- Tone of bladder decrease but ↑tone of vesical sphincter which is used clinically for urine retention
Pharmacological effects of Atropine (Cardiovascular)
- Has duality being displayed (agonist vs musck antag)
- Vagal block with high doses (2 mg). Atropine causes tachycardia
- Used clinically to overcome severe bardycardia due to baroR reflex Therapeutic doses shows dual effects, is from the medulla oblongata with response in heart and increases in dose
- Low dose (0.2 mg) causes bradycardia via CNS response with no direct change in BP Eye effects are mydriasis (pupil dilatation) & cycloplegia through systemic or local administration
Therapeutic Atropine
- Used for blocked secretions (like flushing), GI- antispasmodic, peptic ulcers along with eye dilation
- Used in Lungs- block bronchiole secretions as well as bladder contraction
- Can be used IV for AChase I poisoning
- Long term use may cause urinary retention in the presence of CNS effects
Bronchodilation
- Uses several compounds like AC, CAMP, PDE with Theophylline and Adenosine
Atropine & bronchodilation
- Not generally used for asthma due to duality of M3 and M1 receptor activation
- M3 receptor activation leads to bronchoconstriction and antagonism leads to bronchodilation
- M2 receptors are autoreceptors reduce Ach but increases antagonsim
Other Anti-Muscarinic Agents
- Scopolamine causes CNS effects, is natural or synthetic and is anti-cholinergic
- Treats motion sickness and may be given as a transdermal patch
- Used for postoperative nausea & vomiting. and decreases saliva prior to surgery
- Enters CNS and peripheral effects similar to Atr but causes sedation and can stop breathing
Other Synthetic Anti-Muscarinics
- Rationaly desinged w/ several sites of action that target particlar structures or sites
- Reduce gastric excretions and smooth muscle contration
- Used to treat asthma and Opthalamic problems
Checking In: ANS L3 P1
- Key questions to reviewing and learning this material
Nicotine & nAChR Agonists
- Used to characterize ligand gated ion channels
- It is active and an addicitive ingredient in tobacco that contains several chemicals
- it's absorbed through lipophillic forms and can affect CNS
- Has agonist effects with the autonomic ganglia and causes sympatheitc effects
Nicotine is Toxic
- Toxic exposure causes high BP , twitching that can lead to paralysis
- Chronic users expereience more norepinephirne and vasoconstriction that can influence the developing fetus
Other nACh R Ag
- Includes Lobeline and Arecoline (from betel nut seed) which exhibits multiple effect
Nicotinic R ANT: Ganglionic Blockers
- Used for Hypertension and heart diesase
- Inhibit nACh at the ganglia and effect is on PS vs Sympathetic
- These are no longer used due to other alternatives
Hexamethonium
- Was previously used with effects being noted by WDM POatons
Pharmacological Effects of Ganglionic Blockers
Therapeutic Use of nACh R (ganglia)
Is used through Trimethaphan camsylate (Arfonad) or mecamylamine in IV infusions
Case Study
This is a reference to the earler case study with additional help
Helpful Tips
Are for study teqniques to help learn
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.